Alan Sabirsh (Former)
1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain function
(
- Contribution to journal › Article
- 2018
-
Mark
Human iPS-Derived Astroglia from a Stable Neural Precursor State Show Improved Functionality Compared with Conventional Astrocytic Models
(
- Contribution to journal › Article
- 2016
-
Mark
Reduced baseline sensitivity to Maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency.
(
- Contribution to journal › Letter
- 2005
-
Mark
Pro- and anti-inflammatory substances modulate expression of the leukotriene B4 receptor, BLT1, in human monocytes.
(
- Contribution to journal › Article
- 2004
-
Mark
Exploring the pharmacology of the leukotriene B-4 receptor BLT1, without the confounding effects of BLT2
(
- Contribution to journal › Article
- 2003
-
Mark
Differential inhibition of receptor activation by two mouse monoclonal antibodies specific for the human leukotriene B(4) receptor, BLT(1).
(
- Contribution to journal › Article
-
Mark
Molecular Pharmacology and Structure Function Modelling of the Leukotriene B4 Receptor BLT1
2003)(
- Thesis › Doctoral thesis (compilation)
- 2000
-
Mark
First-generation monoclonal antibodies identifying the human leukotriene B(4) receptor-1
(
- Contribution to journal › Article
- 1998
-
Mark
The leukotriene B4 receptor functions as a novel type of coreceptor mediating entry of primary HIV-1 isolates into CD4-positive cells
(
- Contribution to journal › Article
-
Mark
Molecular mapping of epitopes involved in ligand activation of the human receptor for the neuropeptide, VIP, based on hybrids with the human secretin receptor
(
- Contribution to journal › Article